U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07421739) titled 'Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects' on Jan. 12.
Brief Summary: To assess subject-centric real-world evidence of QoL outcomes in subjects enrolled in the global Phase 3 AU-011-301 clinical trial.
Study Start Date: Nov. 12, 2025
Study Type: OBSERVATIONAL
Condition:
Choroidal Melanoma
Indeterminate Lesions
Uveal Melanoma
Ocular Melanoma
Intervention:
OTHER: Non-interventional, digital, patient-reported, real-world study
Surveys will be collected at the following key timepoints:
Scheduled visits:
Visit 2\_Cycle 1\_Day 1 Visit 8 (week 4, Day 29) Visit 19 (24-hr...